Extrapulmonary manifestations of COVID-19
- PMID: 32651579
- DOI: 10.1038/s41591-020-0968-3
Extrapulmonary manifestations of COVID-19
Abstract
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19. Here we review the extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19 to aid clinicians and scientists in recognizing and monitoring the spectrum of manifestations, and in developing research priorities and therapeutic strategies for all organ systems involved.
Similar articles
-
Extrapulmonary Clinical Manifestations in COVID-19 Patients.Am J Trop Med Hyg. 2020 Nov;103(5):1783-1796. doi: 10.4269/ajtmh.20-0986. Am J Trop Med Hyg. 2020. PMID: 32940201 Free PMC article. Review.
-
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10. J Pathol. 2020. PMID: 32418199 Free PMC article. Review.
-
Immunology of COVID-19: Current State of the Science.Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6. Immunity. 2020. PMID: 32505227 Free PMC article. Review.
-
Severe COVID-19 disease and thromboinflammation.Arch Cardiol Mex. 2020;90(3):257-258. doi: 10.24875/ACM.M20000075. Arch Cardiol Mex. 2020. PMID: 32952161 English. No abstract available.
-
SnapShot: COVID-19.Cell. 2020 May 14;181(4):954-954.e1. doi: 10.1016/j.cell.2020.04.013. Epub 2020 Apr 30. Cell. 2020. PMID: 32413300 Free PMC article.
Cited by
-
Dynamic changes in coagulation parameters and correlation with disease severity and mortality in patients with COVID-19.Aging (Albany NY). 2021 May 24;13(10):13393-13404. doi: 10.18632/aging.203052. Epub 2021 May 24. Aging (Albany NY). 2021. PMID: 34031269 Free PMC article.
-
COVID-19 in trauma: a propensity-matched analysis of COVID and non-COVID trauma patients.Eur J Trauma Emerg Surg. 2021 Oct;47(5):1335-1342. doi: 10.1007/s00068-021-01699-9. Epub 2021 May 25. Eur J Trauma Emerg Surg. 2021. PMID: 34031703 Free PMC article.
-
Immunological Interfaces: The COVID-19 Pandemic and Depression.Front Neurol. 2021 Apr 23;12:657004. doi: 10.3389/fneur.2021.657004. eCollection 2021. Front Neurol. 2021. PMID: 33967944 Free PMC article. Review.
-
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies.Biomed Pharmacother. 2020 Dec;132:110816. doi: 10.1016/j.biopha.2020.110816. Epub 2020 Oct 10. Biomed Pharmacother. 2020. PMID: 33049583 Free PMC article.
-
De novo pancytopaenia in an older adult with severe COVID-19 infection.BMJ Case Rep. 2022 Nov 15;15(11):e252609. doi: 10.1136/bcr-2022-252609. BMJ Case Rep. 2022. PMID: 36379633 Free PMC article.
References
-
- Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020). - PubMed
-
- Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.0950 (2020).
-
- Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2020.0994 (2020).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
